Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ixazomib, lenalidomide, and dexamethasone maintenance in multiple myeloma
NCT02406144Phase 3Completed
- Sponsor
- Fundación PETHEMA
- Start
- Nov 2014
- Primary completion
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ixazomib in multiple myeloma (MM), sponsored by Fundación PETHEMA. Started Nov 2014; status: completed.
02
Drugs
ixazomib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT02406144.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02406144.